American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 2 , Pages 121-133 , March 2009

Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior

  • John F. McGuire, MD, MBA

      Affiliations

    • Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, CA, USA
    • ,
  • Norman N. Ge, MD, FACS

      Affiliations

    • Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, CA, USA
    • Corresponding Author InformationCorresponding author. Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, 16300 Sand Canyon Ave, Suite 201, Irvine, CA 92618, USA. Tel.: +1 949 727 1818; fax: +1 949 727 1819.
    • ,
  • Senait Dyson, MD

      Affiliations

    • Department of Dermatology, University of California, Irvine, CA, USA

Received 14 January 2008

References 

  1. John Chen G, Yelverton CB, Polisetty SS, et al. Treatment patterns and cost of non-melanoma skin cancer management. Dermatol Surg. 2006;32(10):1266–1271
  2. Levi F, La Vecchia C, Te V-C, et al. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer. 1988;42:811–816
  3. Leman JA, McHenry PM. Basal cell carcinoma still an enigma. Arch Dermatol. 2001;137:1239–1240
  4. Bastiaens MT, Hoefnagel JJ, Bruijn JA, et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol. 1998;110(6):880–884
  5. Hutcheson AC, Fisher AH, Lang PG. Basal cell carcinomas with unusual histological patterns. J Am Acad Dermatol. 2005;53(5):833–837
  6. DeFaria JL. Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma?. J Clin Pathol. 1985;38:1273–1277
  7. Borel DM. Cutaneous basosquamous carcinoma. Review of the literature and report of 35 cases. Arch Pathol. 1973;95:293–297
  8. Burg G, Hirsch RD, Konz B, et al. Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermoatol Surg. 1975;1:21
  9. Salasche SH, Ammonette RA. Morpheiform basal cell epitheliomas: a study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol. 1981;7:387
  10. Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer. 1982;49:533–537
  11. Lang PG, Maize JC. Histological evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol. 1986;14:186–196
  12. Wade TR, Ackerman AB. The many faces of basal cell carcinoma. J Dermatol Surg Oncol. 1978;4:23–28
  13. Emmett AJJ, Weedon D. Basal cell carcinoma. In:  Emmett AJJ,  O'Rourke MGE editor. Malignant Skin Tumours. New York: Churchill Livingstone; 1982;p. 30–66
  14. Siegle RJ, MacMillan J, Pollack SV. Infiltrative basal cell carcinoma: a nonsclerosing subtype. J Dermatol Surg Oncol. 1986;12:830–836
  15. Weedon D. Tumours of the epidermis. In:  Weedon D editors. The Skin. Edinburgh: Churchill Livingstone; 1992;p. 729–776
  16. Ackerman AB, DeViragh PA, Chongchitnant N. In: Neoplasms with follicular differentiation. Philadelphia: Lea & Febiger; 1993;p. 605–658
  17. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41–47Cancer. 2003;98(12):2708–2714
  18. Von Domarus H, Steven PJ. Metastatic basal cell carcinoma report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10:1043–1060
  19. Levine HL, Bailin PL. Basal cell carcinoma of the head and neck: identification of the high risk patient. Laryngoscope. 1980;90(6):955–961
  20. Levin HL. Cutaneous carcinoma of the head and neck: management of massive and previously uncontrolled lesions. Laryngoscope. 1983;93(1):87–105
  21. Bart RS, Kopf AW, Petratos MA. X-ray therapy of skin cancer: evaluation of a “standardized” method for treating basal-cell epitheliomas. In: Sixth National Cancer Conference Proceedings. Philadelphia: JP Lippincott; 1970;
  22. Zagrodnik B, Kempf W, Seifert B, Muller B, Burg G, Urosevic M, Dummer R. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
  23. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136(12):1524–1530
  24. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5 Pt 1):774–778
  25. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63(1-3):8–18
  26. de Gruijl FR. Photocarcinogenesis: UVA vs UVB. Methods Enzymol. 2000;319:359–366
  27. Drolet BA, Neuburg M, Sanger J. Role of human papillomavirus in cutaneous oncogenesis. Ann Plast Surg. 1994;33(3):339–347
  28. Esther RJ, Lamps L, Schwartz HS. Marjolin ulcers: secondary carcinomas in chronic wounds. J South Orthop Assoc. 1999;8(3):181–187
  29. Perry PK, Silverberg NB. Cutaneous malignancy in albinism. Cutis. 2001;67(5):427–430
  30. Czarnecki D, Meehan CJ, Bruce F, et al. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg. 2002;6(3):207–209
  31. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutan Pathol. 2006;33(3):191–206[Review]
  32. Wick MR, Fitzgibbon JF, Swanson PE. Cutaneous sarcomas and sarcomatoid neoplasms of the skin. Semin Diagn Pathol. 1993;10:148–158
  33. Bernstein SC, Lim KK, Brodland DG, et al. The many faces of squamous cell carcinoma. Dermatol Surg. 1996;22:243–254
  34. Heintz PW, White CR. Diagnosis-atypical fibroxanthoma or not? Evaluating spindle cell malignancies on sun damaged skin: a practical approach. Semin Cutan Med Surg. 1999;18:78–83
  35. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification–part two. J Cutan Pathol. 2006;33(4):261–279[Review]
  36. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53(2):261–266
  37. Levine H, Bailin P, Wood B, et al. Tissue conservation in treatment of cutaneous neoplasms of the head and neck: combined use of Mohs' chemosurgical and conventional surgical techniques. Arch Otolaryngol. 1979;105:140–144
  38. Levine JL, Bailin PL. Basal cell carcinoma of the head and neck: identification of the high-risk patient. Laryngoscope. 1980;90:955–961
  39. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. J Am Acad Dermatol. 1989;21:241–248
  40. Rowe DE, Carroll RH, Day CL. Prognostic factor for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol. 1992;26:976–990
  41. Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys. 2001;49(4):1061–1069
  42. Ratner D, Lowe L, Johnson TM, et al. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer. 2000;88(7):1605–1613
  43. Backous DD, DeMonte F, El-Naggar A, et al. Craniofacial resection for nonmelanoma skin cancer of the head and neck. Laryngoscope. 2005;115(6):931–937
  44. McCord MW, Mendenhall WM, Parsons JT, et al. Skin cancer of the head and neck with clinical perineural invasion. Int J Radiat Oncol Biol Phys. 2000;47(1):89–93
  45. McCord MW, Mendenhall WM, Parsons JT, et al. Skin cancer of the head and neck with incidental microscopic perineural invasion. Int J Radiat Oncol Biol Phys. 1999;43(3):591–595
  46. Hruza GJ. Mohs micrographic surgery. Otolaryngol Clin North Am. 1990;23(5):845–864
  47. Shriner DL, McCoy DK, Goldberg DJ, et al. Mohs micrographic surgery. J Am Acad Dermatol. 1998;39(1):79–97
  48. Khurana VG, Mentis DH, O'Brien CJ, et al. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg. 1995;170(5):446–450
  49. Hong TS, Kriesel KJ, Hartig GK, et al. Parotid area lymph node metastases from cutaneous squamous cell carcinoma: implications for diagnosis, treatment, and prognosis. Head Neck. 2005;27(10):851–856
  50. Vauterin TJ, Veness MJ, Morgan GJ, et al. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2006;28(9):785–791
  51. O'Brien CJ, McNeil EB, McMahon JD, et al. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck. 2001;23(9):744–748
  52. Veness MJ, Morgan GJ, Palme CE, et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115(5):870–875
  53. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–990[Review]
  54. Bentz BG, Singh B, Woodruff J, et al. Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann Surg Oncol. 2004;11(6):619–628
  55. Stojadinovic A, Karpoff HM, Antonescu CR, et al. Dermatofibrosarcoma protuberans of the head and neck. Ann Surg Oncol. 2000;7(9):696–704
  56. Bowne WB, Antonescu CR, Leung DH, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88(12):2711–2720
  57. Tom WD, Hybarger CP, Rasgon BM. Dermatofibrosarcoma protuberans of the head and neck: treatment with Mohs surgery using inverted horizontal paraffin sections. Laryngoscope. 2003;113(8):1289–1293
  58. Ratner D, Thomas CO, Johnson TM, et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol. 1997;37(4):600–613
  59. Prieto VG, Reed JA, Shea CR. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol. 1994;21(4):324–329
  60. Abbott JJ, Oliveira AM, Nascimento AG. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol. 2006;30(4):436–443
  61. Mentzel T, Beham A, Katenkamp D, et al. Fibrosarcomatous (“high-grade”) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22(5):576–587
  62. Khatri VP, Galante JM, Bold RJ, et al. Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol. 2003;10(9):1118–1122
  63. Simman R, DeFranzo A, Sanger C, et al. Dermatofibrosarcoma protuberans of the face: surgical management. J Craniofac Surg. 2005;16(3):439–443
  64. Ballo MT, Zagars GK, Pisters P, et al. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys. 1998;40(4):823–827
  65. Suit H, Spiro I, Mankin HJ, et al. Radiation in management of patients with dermatofibrosarcoma protuberans. J Clin Oncol. 1996;14(8):2365–2369
  66. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107–110
  67. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89(1):1–4
  68. Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52(1):101–108
  69. Eng TY, Boersma MG, Fuller CD, et al. Treatment of Merkel cell carcinoma. Am J Clin Oncol. 2004;27(5):510–515
  70. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–841
  71. Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780–1781
  72. Sidhu GS, Chandra P, Cassai ND. Merkel cells, normal and neoplastic: an update. Ultrastruct Pathol. 2005;29(3-4):287–294[Review]
  73. Koljonen VS. Merkel cell carcinoma. World J Surg Oncol. 2006;4(1):7;[electronic publication ahead of print]
  74. Sandel HD, Day T, Richardson MS, et al. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?. Laryngoscope. 2006;116(5):791–795
  75. Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47(6):885–892[Review]
  76. Brissett AE, Olsen KD, Kasperbauer JL, et al. Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck. 2002;24(11):982–988
  77. Sian KU, Wagner JD, Sood R, et al. Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. Ann Plast Surg. 1999;42(6):679–682
  78. Gupta SG, Wang LC, Penas PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142(6):685–690
  79. Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300–2309
  80. Schmalbach CE, Lowe L, Teknos TN, et al. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg. 2005;131(7):610–614
  81. Veness MJ. Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview on management. Australas J Dermatol. 2006;47(3):160–165
  82. Alsaad KO, Obaidat NA, Ghazarian D. Skin adnexal neoplasms–part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol. 2006;[electronic publication ahead of print]
  83. Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasms–part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol. 2006;[electronic publication ahead of print]
  84. Crowson AN, Magro CM, Mihm MC. Malignant adnexal neoplasms. Mod Pathol. 2006;19(Suppl 2):S93–S126[Review]
  85. Leibovitch I, Huilgol SC, Richards S, et al. Periocular microcystic adnexal carcinoma: management and outcome with Mohs' micrographic surgery. Ophthalmologica. 2006;220(2):109–113
  86. Durairaj VD, Hink EM, Kahook MY, et al. Mucinous eccrine adenocarcinoma of the periocular region. Ophthal Plast Reconstr Surg. 2006;22(1):30–35
  87. Tierney E, Ochoa MT, Rudkin G, et al. Mohs' micrographic surgery of a proliferating trichilemmal tumor in a young black man. Dermatol Surg. 2005;31(3):359–363
  88. Cowden A, Dans M, Militello G, et al. Eccrine porocarcinoma arising in two African American patients: distinct presentations both treated with Mohs micrographic surgery. Int J Dermatol. 2006;45(2):146–150
  89. Hodgson TA, Haricharan AK, Barrett AW, et al. Microcystic adnexal carcinoma: an unusual cause of swelling and paraesthesia of the lower lip. Oral Oncol. 2003;39(2):195–198[Review]
  90. Friedman PM, Friedman RH, Jiang SB, et al. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol. 1999;41(2 Pt 1):225–231[Review]
  91. Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg. 2001;27(4):401–408[Review]
  92. Chu A, Osguthorpe JD. Nonmelanoma cutaneous malignancy with regional metastasis. Otolaryngol Head Neck Surg. 2003;128(5):663–673
  93. Lai SY, Weinstein GS, Chalian AA, et al. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg. 2002;128(5):521–526
  94. Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck. 2004;26(8):727–732
  95. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer. 2006;106(5):1078–1083
  96. Palme C, O'Brien C, Veness M, et al. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:750–753
  97. Yoon M, Chougule P, Dufresne R, et al. Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg. 1992;164(6):574–577[Review]
  98. Choi JY, Choi EC, Lee HK, et al. Mode of parotid involvement in external auditory canal carcinoma. J Laryngol Otol. 2003;117(12):951–954
  99. Moore BA, Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115(9):1561–1567
  100. Ch'ng S, Maitra A, Lea R, et al. Parotid metastasis—an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg. 2006;59(12):1288–1293
  101. Barzilai G, Greenberg E, Cohen-Kerem R, et al. Pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2005;132(6):852–856
  102. Ying YL, Johnson JT, Myers EN. Squamous cell carcinoma of the parotid gland. Head Neck. 2006;28(7):626–632
  103. Lee K, McKean ME, McGregor IA. Metastatic patterns of squamous carcinoma in the parotid lymph nodes. Br J Plast Surg. 1985;38(1):6–10
  104. Dona E, Veness MJ, Cakir B, et al. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg. 2003;73(9):692–696
  105. Taylor BW, Brant TA, Mendenhall NP, et al. Carcinoma of the skin metastatic to parotid area lymph nodes. Head Neck. 1991;13(5):427–433
  106. Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143(3):513–519
  107. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(2 Pt 1):177–186
  108. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681–1691
  109. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1–17[quiz 18-20]
  110. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol. 2006;154(3):498–504
  111. Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg. 2004;30(4 Pt 2):642–650
  112. Hoglund P. DNA damage and tumor surveillance: one trigger for two pathways. Sci STKE. 2006;2006(317):pe2;[Review]
  113. Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol. 2006;54(2):290–300
  114. Bouwes Bavinck JN, Feltkamp M, Struijk L, et al. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc. 2001;6(3):207–211[Review]
  115. Stockfleth E, Nindl I, Sterry W, et al. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg. 2004;30(4 Pt 2):604–609
  116. de Graaf YG, Basdew VR, van Zwan-Kralt N, et al. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation. Br J Dermatol. 2006;154(3):493–497
  117. Martinez JC, Otley CC, Stasko T, et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol. 2003;139(3):301–306
  118. Lindelof B, Jarnvik J, Ternesten-Bratel A, et al. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort. Acta Derm Venereol. 2006;86(3):219–222
  119. Smith KJ, Hamza S, Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg. 2004;30(4 Pt 2):634–641
  120. Carucci JA, Martinez JC, Zeitouni NC, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg. 2004;30(4 Pt 2):651–655
  121. De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg. 2004;30(4 Pt 2):656–661[Review]
  122. Ulrich C, Busch JO, Meyer T, et al. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases. Br J Dermatol. 2006;155(2):451–454
  123. Martinez JC, Otley CC, Okuno SH, et al. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations. Dermatol Surg. 2004;30(4 Pt 2):679–686[Review]

PII: S0196-0709(08)00046-X

doi: 10.1016/j.amjoto.2008.03.002

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 2 , Pages 121-133 , March 2009

Article Tools

* Image Usage & Resolution